HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP
Delisted
HZNP was delisted on the 5th of October, 2023.
264 hedge funds and large institutions have $4.54B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 81 increasing their positions, 112 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
264
Holders Change
-8
Holders Change %
-2.94%
% of All Funds
5.8%
Holding in Top 10
12
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+100%
% of All Funds
0.26%
New
40
Increased
81
Reduced
112
Closed
47
Calls
$17.2M
Puts
$8.32M
Net Calls
+$8.92M
Net Calls Change
+$13M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
$87.2M |
| 2 |
PC
Paulson & Co
New York
|
$222M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
$40.7M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
$227M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
$80.4M |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
$24.9M |
| 2 |
BlackRock
New York
|
$287M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
$11.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$13.6M |
| 5 |
Goldman Sachs
New York
|
$17.3M |
